Drug Type Microbiota |
Synonyms- |
Target- |
Action- |
Mechanism Bacteria replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Intestinal Diseases | Preclinical | South Korea | 25 Mar 2026 |





